Methods Validation Assessment for Study of Inflammatory Skin Disease
NCT03796806 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2021-10-08
Summary
1. Assess validity of methods involved in molecular studies of the skin in inflammatory skin disease
2. Assess feasibility of methods for grafting fresh human skin (normal and diseased with inflammatory skin disease) onto an established xenograft murine model.
Conditions
- Lichen Planus
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Julia S Lehman · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-14
- Primary Completion
- 2019-01-14
- Completion
- 2019-01-14
Countries
- United States
Study Locations
More Related Trials
-
Evaluation and Treatment of Patients With Dermatologic Diseases
NCT00001506 ·Status: COMPLETED
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
NCT00001505 ·Status: COMPLETED
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
NCT04864886 ·Status: RECRUITING
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
Gene Polymorphism in Tinea Versicolor
NCT04769804 ·Status: UNKNOWN
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784 ·Status: COMPLETED
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Koebner's Phenomenon in Psoriasis and Lichen Planus
NCT06021405 ·Status: WITHDRAWN ·Phase: NA
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA
-
Molecular Signatures in Inflammatory Skin Disease
NCT03358693 ·Status: RECRUITING
-
Research in Skin Inflammation
NCT00026741 ·Status: COMPLETED
-
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
NCT05189925 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars
NCT04707924 ·Status: WITHDRAWN ·Phase: NA
-
Translational Assessment of Vitiligo According to Body Locations
NCT06068218 ·Status: COMPLETED ·Phase: NA
-
Fire Needle Therapy on Plaque Psoriasis With Blood Stasis Syndrome
NCT03953885 ·Status: UNKNOWN ·Phase: NA
-
Vulvar Mucosal Specialty Clinic Chart Review
NCT02881229 ·Status: TERMINATED
-
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
NCT03198390 ·Status: TERMINATED
-
Vulvar Scarring Grading Scale for Lichen Sclerosus
NCT02880904 ·Status: TERMINATED
-
Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa
NCT03578029 ·Status: TERMINATED ·Phase: PHASE2
-
Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa
NCT04727268 ·Status: UNKNOWN
-
Addressing Inequity in Dermatology
NCT06056648 ·Status: RECRUITING